Literature DB >> 25038728

Adiponectin, cardiovascular disease, and mortality: parsing the dual prognostic implications of a complex adipokine.

Jorge R Kizer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25038728      PMCID： PMC4170851          DOI： 10.1016/j.metabol.2014.06.011

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  39 in total

1.  Identifiability and exchangeability for direct and indirect effects.

Authors:  J M Robins; S Greenland
Journal:  Epidemiology       Date:  1992-03       Impact factor: 4.822

2.  Adiponectin and myocardial infarction: A paradox or a paradigm?

Authors:  Hwee Teoh; Martin H Strauss; Paul E Szmitko; Subodh Verma
Journal:  Eur Heart J       Date:  2006-09-07       Impact factor: 29.983

Review 3.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity.

Authors:  Herbert Tilg; Alexander R Moschen
Journal:  Nat Rev Immunol       Date:  2006-09-22       Impact factor: 53.106

4.  Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure.

Authors:  S Goya Wannamethee; Peter H Whincup; Lucy Lennon; Naveed Sattar
Journal:  Arch Intern Med       Date:  2007-07-23

Review 5.  Adipose tissue: from lipid storage compartment to endocrine organ.

Authors:  Philipp E Scherer
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

6.  Adiponectin and coronary heart disease: a prospective study and meta-analysis.

Authors:  Naveed Sattar; Goya Wannamethee; Nadeem Sarwar; Julia Tchernova; Lynne Cherry; A Michael Wallace; John Danesh; Peter H Whincup
Journal:  Circulation       Date:  2006-08-07       Impact factor: 29.690

Review 7.  Cardiometabolic effects of adiponectin.

Authors:  Jennifer L Parker-Duffen; Kenneth Walsh
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-09-13       Impact factor: 4.690

Review 8.  Adiponectin and cardiovascular disease: state of the art?

Authors:  Paul E Szmitko; Hwee Teoh; Duncan J Stewart; Subodh Verma
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-12-01       Impact factor: 4.733

9.  Adiponectin and mortality in patients with chronic kidney disease.

Authors:  Vandana Menon; Lijun Li; Xuelei Wang; Tom Greene; Vaidyanathapuram Balakrishnan; Magdalena Madero; Arema A Pereira; Gerald J Beck; John W Kusek; Allan J Collins; Andrew S Levey; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

10.  Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain.

Authors:  Erdal Cavusoglu; Cyril Ruwende; Vineet Chopra; Sunitha Yanamadala; Calvin Eng; Luther T Clark; David J Pinsky; Jonathan D Marmur
Journal:  Eur Heart J       Date:  2006-07-24       Impact factor: 29.983
View more
  19 in total

1.  Trajectories of function and biomarkers with age: the CHS All Stars Study.

Authors:  Anne B Newman; Jason L Sanders; Jorge R Kizer; Robert M Boudreau; Michelle C Odden; Adina Zeki Al Hazzouri; Alice M Arnold
Journal:  Int J Epidemiol       Date:  2016-06-06       Impact factor: 7.196

2.  Higher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes.

Authors:  Corinna Niersmann; Maren Carstensen-Kirberg; Haifa Maalmi; Bernd Holleczek; Michael Roden; Hermann Brenner; Christian Herder; Ben Schöttker
Journal:  Diabetologia       Date:  2019-11-09       Impact factor: 10.122

3.  Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults.

Authors:  Fima Macheret; Traci M Bartz; Luc Djousse; Joachim H Ix; Kenneth J Mukamal; Susan J Zieman; David S Siscovick; Russell P Tracy; Susan R Heckbert; Bruce M Psaty; Jorge R Kizer
Journal:  Heart       Date:  2015-04-08       Impact factor: 5.994

4.  C1q/TNF-Related Proteins, HIV and HIV-Associated Factors, and Cardiometabolic Phenotypes in Middle-Aged Women.

Authors:  Michal Kasher Meron; Shuo Xu; Marshall J Glesby; Qibin Qi; David B Hanna; Kathryn Anastos; Robert C Kaplan; Jorge R Kizer
Journal:  AIDS Res Hum Retroviruses       Date:  2019-09-03       Impact factor: 2.205

Review 5.  New and emerging biomarkers in cardiovascular disease.

Authors:  Leah E Cahill; Monica L Bertoia; Sarah A Aroner; Kenneth J Mukamal; Majken K Jensen
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

6.  Adiponectin circulating levels and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA Study.

Authors:  Ioannis Kyrou; Olga Tsantarlioti; Demosthenes B Panagiotakos; Constantine Tsigos; Ekavi Georgousopoulou; Christina Chrysohoou; Ioannis Skoumas; Dimitrios Tousoulis; Christodoulos Stefanadis; Christos Pitsavos
Journal:  Endocrine       Date:  2017-10-16       Impact factor: 3.633

7.  Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients.

Authors:  Hannah Mathew; Olivia M Farr; Christos S Mantzoros
Journal:  Metabolism       Date:  2015-10-23       Impact factor: 8.694

8.  PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome.

Authors:  Hong Chen; Abul Fajol; Miriam Hoene; Bingbing Zhang; Erwin D Schleicher; Yun Lin; Carsten Calaminus; Bernd J Pichler; Cora Weigert; Hans U Häring; Florian Lang; Michael Föller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-02       Impact factor: 11.205

9.  Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study.

Authors:  Christian Stevns Hansen; Dorte Vistisen; Marit Eika Jørgensen; Daniel R Witte; Eric J Brunner; Adam G Tabák; Mika Kivimäki; Michael Roden; Marek Malik; Christian Herder
Journal:  Cardiovasc Diabetol       Date:  2017-12-01       Impact factor: 9.951

10.  Prediction of coronary disease incidence by biomarkers of inflammation, oxidation, and metabolism.

Authors:  Isaac Subirana; Montserrat Fitó; Oscar Diaz; Joan Vila; Albert Francés; Eva Delpon; Juan Sanchis; Roberto Elosua; Daniel Muñoz-Aguayo; Irene R Dégano; Jaume Marrugat
Journal:  Sci Rep       Date:  2018-02-16       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.